These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 440371)

  • 1. Testing for doxorubicin cardiotoxicity.
    Alexander J; Berger HJ; Zaret BL
    N Engl J Med; 1979 Jun; 300(24):1393. PubMed ID: 440371
    [No Abstract]   [Full Text] [Related]  

  • 2. Testing for doxorubicin cardiotoxicity.
    Hoefling B; Zaehringer J; Bolte HD
    N Engl J Med; 1979 Jun; 300(24):1392. PubMed ID: 440370
    [No Abstract]   [Full Text] [Related]  

  • 3. Testing for doxorubicin cardiotoxicity.
    Bristow MR
    N Engl J Med; 1979 Jun; 300(24):1393. PubMed ID: 440372
    [No Abstract]   [Full Text] [Related]  

  • 4. Adriamycin cardiotoxicity and calcium entry blockers: the need for caution in the combination.
    Rabkin SW; Godin DV
    Can J Cardiol; 1985; 1(5):IV-VII. PubMed ID: 3021301
    [No Abstract]   [Full Text] [Related]  

  • 5. Testing for doxorubicin cardiotoxicity.
    Henderson IC; Frei E
    N Engl J Med; 1979 Jun; 300(24):1393-4. PubMed ID: 440374
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of Doxorubicin cardiotoxicity by iron loading in a rodent model.
    Panjrath GS; Patel V; Valdiviezo CI; Narula N; Narula J; Jain D
    J Am Coll Cardiol; 2007 Jun; 49(25):2457-64. PubMed ID: 17599610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of doxorubicin-induced cardiotoxicity in mice by taurine.
    Hamaguchi T; Azuma J; Awata N; Ohta H; Takihara K; Harada H; Kishimoto S; Sperelakis N
    Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):21-30. PubMed ID: 3353577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of verapamil on doxorubicin cardiotoxicity: altered muscle gene expression in cultured neonatal rat cardiomyocytes.
    Akimoto H; Bruno NA; Slate DL; Billingham ME; Torti SV; Torti FM
    Cancer Res; 1993 Oct; 53(19):4658-64. PubMed ID: 8402643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of doxorubicin on glutathione and glutathione-dependent enzymes in cultured rat heart cells.
    Paranka NS; Dorr RT
    Anticancer Res; 1994; 14(5A):2047-52. PubMed ID: 7847848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trifluoperazine does not affect doxorubicin cardiotoxicity in the rat.
    Villani F; Monti E; Piccinini F; Favalli L; Rozza Dionigi A; Lanza E; Poggi P
    Anticancer Res; 1988; 8(4):659-63. PubMed ID: 3178155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity.
    Bai P; Mabley JG; Liaudet L; Virág L; Szabó C; Pacher P
    Oncol Rep; 2004 Feb; 11(2):505-8. PubMed ID: 14719091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental cardiotoxicity of adriamycin].
    Bertazzoli C; Solcia E; Sala L; Dell'oro I; Rovero C; Caccia G
    G Ital Chemioter; 1975; 22(1-2):19-26. PubMed ID: 1235347
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.
    Arola OJ; Saraste A; Pulkki K; Kallajoki M; Parvinen M; Voipio-Pulkki LM
    Cancer Res; 2000 Apr; 60(7):1789-92. PubMed ID: 10766158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of Gingko biloba extract against doxorubicin-induced cardiotoxicity in mice.
    Naidu MU; Kumar KV; Mohan IK; Sundaram C; Singh S
    Indian J Exp Biol; 2002 Aug; 40(8):894-900. PubMed ID: 12597018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity.
    Herman EH; Lipshultz SE; Rifai N; Zhang J; Papoian T; Yu ZX; Takeda K; Ferrans VJ
    Cancer Res; 1998 Jan; 58(2):195-7. PubMed ID: 9443390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity.
    Adachi K; Fujiura Y; Mayumi F; Nozuhara A; Sugiu Y; Sakanashi T; Hidaka T; Toshima H
    Biochem Biophys Res Commun; 1993 Sep; 195(2):945-51. PubMed ID: 8373427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthracycline cardiotoxicity in the rat: relationship between ECG changes and morphologic effects induced by different analogues.
    Villani F; Favalli L; Lanza E; Rozza-Dionigi A; Poggi P
    Chemioterapia; 1987 Jun; 6(2 Suppl):688-90. PubMed ID: 3509523
    [No Abstract]   [Full Text] [Related]  

  • 19. Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy.
    Minotti G; Ronchi R; Salvatorelli E; Menna P; Cairo G
    Cancer Res; 2001 Dec; 61(23):8422-8. PubMed ID: 11731422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of S-adenosylmethionine (SAMe) on doxorubicin-induced cardiotoxicity in the rat.
    Russo S; Filippelli W; Ferraraccio F; Berrino L; Guarino V; Rossi F
    J Med; 1994; 25(1-2):65-89. PubMed ID: 7930959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.